Published online Apr 28, 2023. doi: 10.3748/wjg.v29.i16.2380
Peer-review started: September 18, 2022
First decision: November 26, 2022
Revised: January 26, 2023
Accepted: April 7, 2023
Article in press: April 7, 2023
Published online: April 28, 2023
Processing time: 218 Days and 11.1 Hours
Ulcerative colitis (UC) is a chronic nonspecific inflammatory disease with complex causes. The main pathological changes were intestinal mucosal injury. Leucine-rich repeat-containing G protein coupled receptor 5 (LGR5)-labeled small intestine stem cells (ISCs) were located at the bottom of the small intestine recess and inlaid among Paneth cells. LGR5+ small ISCs are active proliferative adult stem cells, and their self-renewal, proliferation and differentiation disorders are closely related to the occurrence of intestinal inflammatory diseases. The Notch signaling pathway and Wnt/β-catenin signaling pathway are important regulators of LGR5-positive ISCs and together maintain the function of LGR5-positive ISCs. More importantly, the surviving stem cells after intestinal mucosal injury accelerate division, restore the number of stem cells, multiply and differentiate into mature intestinal epithelial cells, and repair the damaged intestinal mucosa. Therefore, in-depth study of multiple pathways and transplantation of LGR5-positive ISCs may become a new target for the treatment of UC.
Core Tip: Intestinal mucosal injury is an important pathological change in ulcerative colitis (UC), and Leucine-rich repeat-containing G protein coupled receptor 5 (LGR5)-positive intestinal stem cells play an important role in the repair of intestinal mucosal injury. Through in-depth study of multiple signals, LGR5-positive intestine stem cell transplantation therapy may become an important means to treat UC.